Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2018 September;60(3) > Panminerva Medica 2018 September;60(3):136-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Panminerva Medica 2018 September;60(3):136-7

DOI: 10.23736/S0031-0808.18.03446-8

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Why is there an emerging need to look for a suitable drug delivery platform in targeting and regulating microbiota?

Kamal DUA 1, 2, 3 , Gaurav GUPTA 4, Rajendra AWASTHI 5, Dinesh K. CHELLAPPAN 6

1 Section of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; 2 School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; 3 Priority Research Center for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia; 4 Jaipur National University, School of Pharmaceutical Sciences, Jagatpura, Jaipur, India; 5 NKBR College of Pharmacy and Research Center, Meerut, India; 6 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia


PDF


top of page